Greater Cincinnati biotech firm developing cure for disease just raised millions
Airway Therapeutics, a Sharonville biotechnology company developing a way to prevent and treat lung disease in premature babies, has raised $11 million in Series B financing from new and existing investors.
The firm is developing a protein replacement therapy called AT-100, which is based on research conducted by Dr. Jeffrey Whitset at Cincinnati Children’s Hospital Medical Center. Airway Therapeutics was created in 2011 as a spin-out of Cincinnati Children’s.
“Our hardworking team is…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news
More News: Babies | Biotechnology | Health Management | Hospitals | Perinatology & Neonatology | Pharmaceuticals | Premature Birth